P120 Upadacitinib for Moderate-to-severe Ulcerative Colitis: Interim Results from U-ACTIVATE Phase III Open-Label Extension
Poster Presentations(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined